A rare restriction enzyme site polymorphism in the breakpoint cluster region (bcr) of chromosome 22

Leukemia. 1988 Nov;2(11):760-2.

Abstract

Detection of rearrangement of the breakpoint cluster region (bcr) of chromosome 22 by Southern blot analysis can be used for the routine diagnosis of CML. Restriction fragment length polymorphisms (RFLPs) in the bcr can potentially be confused with translocation since both alter the size of DNA fragments obtained. By digesting DNA with the restriction enzyme BamHl and analyzing with probes commonly used for identifying rearrangement of the bcr, we have observed a RFLP within the bcr. For one CML patient studied in detail, the presence of the polymorphism was confirmed by comparing the results of analyses of granulocytes and a T cell-enriched population. The same polymorphism was detected in three additional CML patients and a patient with thrombocytosis. For the diagnosis of CML, verification of rearrangement with multiple probes and/or restriction enzyme combinations is necessary to rule out false positives, as well as to reduce the chance of false negatives due to co-migration of DNA fragments.

MeSH terms

  • Adult
  • Bacterial Proteins*
  • Blotting, Southern
  • Chromosomes, Human, Pair 22*
  • DNA, Neoplasm / genetics
  • DNA, Neoplasm / isolation & purification
  • Deoxyribonuclease HindIII
  • Deoxyribonucleases, Type II Site-Specific
  • Gene Rearrangement
  • Humans
  • Leukemia, Myeloid, Chronic-Phase / genetics*
  • Leukemia, Myeloid, Chronic-Phase / metabolism
  • Leukemia, Myeloid, Chronic-Phase / pathology
  • Male
  • Polymorphism, Genetic*
  • Polymorphism, Restriction Fragment Length*
  • Translocation, Genetic*

Substances

  • Bacterial Proteins
  • DNA, Neoplasm
  • Deoxyribonuclease HindIII
  • BglII endonuclease
  • Deoxyribonucleases, Type II Site-Specific